Work has begun in the UK on developing new tests that will spot if someone has “fat genes”. The project, which seeks to ...

Novo Nordisk remains financially strong, but pricing pressures and CagriSema challenges limit near-term upside. Find out why ...

The head of Zealand Pharma has called its $5.3bn partnership with Roche to commercialise an obesity drug with fewer ...

If you value the S&P 500 on earnings, its price-to-earnings ratio of 28 is also significantly above its historical norms. The Vanguard FTSE Developed Markets ETF trades at 15.5 times earnings today, a ...

Factories in China Factories in China are posting content on social platforms about the true cost to produce a luxury He ...

If found to be lacking adequate compliance systems, Moderna could ultimately be suspended or expelled from the Association of ...